Raymond James Downgrades Disc Medicine (IRON) to Outperform, ‘Mixed Outcome as Key Secondaries Miss Due to Large Placebo Response’

Visit StreetInsider.com at http://www.streetinsider.com/Analyst+PT+Change/Raymond+James+Downgrades+Disc+Medicine+%28IRON%29+to+Outperform%2C+%27Mixed+Outcome+as+Key+Secondaries+Miss+Due+to+Large+Placebo+Response%27/23005184.html for the full story.